CME Group CME reported second-quarter 2024 adjusted earnings per share of $2.56, which beat the Zacks Consensus Estimate by 2%. The bottom line increased 11.3% year over year.
Quarterly results benefited from a record in trading volumes. Average daily volume increased in its six asset classes with average daily volume (ADV) up 16% in commodities and 13% in financial markets.
Shares gained 1.2% in the pre-market trading session to reflect the outperformance.
CME Group Inc. Price, Consensus and EPS Surprise
CME Group Inc. price-consensus-eps-surprise-chart | CME Group Inc. Quote
Performance in Detail
CME Group’s revenues of $1.5 billion increased 12.5% year over year. The year-over-year increase was primarily due to higher clearing and transaction fees (up 11.8% year over year), market data and information services (up 7.3% year over year) and other (36.8% year over year). The top line beat the Zacks Consensus Estimate by almost 1%.
Total expenses inched up 2% year over year to $531.9 million, attributable to higher technology, and licensing and other fee agreements. It exceeded our estimate of $552.4 million.
Operating income increased 20% from the prior-year quarter to $1 billion. Our estimate was $961.8 million.
ADV was 25.9 million contracts, including non-U.S. ADV, which reached a record 7.8 million contracts. The total average rate per contract was 70.8 cents.
Financial Update
As of Jun 30, 2024, CME Group had $2 billion of cash and marketable securities, down 48.5% from the 2023-end level.
As of Jun 30, 2024, long-term debt was $2.7 billion, down 21.7% from 2023-end. As of Jun 30, 2024, CME had shareholders' equity worth $27.6 billion, up 3.4% from the end of 2023.
Capital Deployment
CME Group paid out $419 billion in dividends, taking the payout to $25.2 billion since the implementation of the variable dividend policy in early 2012.
Zacks Rank
CME Group currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Upcoming Releases
Nasdaq NDAQ will report second-quarter 2024 results on Jul 25, before market open. The Zacks Consensus Estimate for second-quarter earnings per share is pegged at 64 cents, suggesting a decrease of 9.9% from the year-ago quarter’s reported figure.
NDAQ’s earnings beat estimates in three of the last four quarters while missing in the remaining one.
Intercontinental Exchange ICE will report second-quarter 2024 results on Aug 1, before market open. The Zacks Consensus Estimate for second-quarter earnings per share is pegged at $1.48, indicating an increase of 3.5% from the year-ago quarter’s reported figure.
ICE’s earnings beat estimates in each of the last four quarters.
Cboe Global Markets CBOE will report second-quarter 2024 results on Aug 2, before market open. The Zacks Consensus Estimate for second-quarter earnings per share is pegged at $2.09, suggesting an increase of 17.4% from the year-ago quarter’s reported figure.
CBOE’s earnings beat estimates in each of the last four reported quarters.
Check Out These Stocks Before They Report Earnings (Free Report)
A stock can jump +10-20% in a single day after a positive earnings surprise. What if you could get in early on those stocks? It could be the "holy grail" of stock picking for investors.
Zacks' new special report is designed to do exactly that. It reveals 5 promising stocks experts predict will crush earnings estimates and skyrocket in price.
Download Earnings Season Profit Secrets today, absolutely free.Intercontinental Exchange Inc. (ICE) : Free Stock Analysis Report
CME Group Inc. (CME) : Free Stock Analysis Report
Nasdaq, Inc. (NDAQ) : Free Stock Analysis Report
Cboe Global Markets, Inc. (CBOE) : Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
